Overview

Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of etanercept when used in the first trimester of pregnancy with respect to major structural birth defects of newborns. This is an observational study only - no investigational product is used.
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept